Searchable abstracts of presentations at key conferences on calcified tissues

ba0002p69 | (1) | ICCBH2013

sRANKL/OPG in children with idiopathic hypercalciuria

Pavlou Maria , Siomou Ekaterini , Cholevas Vasileios , Siamopoulou Antigone , Challa Anna

Objectives: To determine any relationship of serum concentrations of osteoprotegerin (OPG), sRANKL and sRANKL:OPG ratio with idiopathic hypercalciuria (IH) in children, as there is some evidence of increased bone resorption in these patients.Methods: In a prospective study, twenty four children of median age 6.5 years (range 2.3–16.4) with IH (five had urolithiasis and two nephrocalcinosis) were examined at the time of diagnosis and after 3 months o...

ba0002p113 | (1) | ICCBH2013

Everyday chemicals modulate bone properties during development

Herlin Maria , Bjorkeson Ewa , Bowers Wayne J , Hakansson Helen

Objectives: In the modern society, all individuals are exposed throughout life to a variety of chemicals, which may contribute significantly to the human disease burden. Most of these chemicals are transferred to the fetus in-utero and to the infant via mother’s milk. Until recently, few studies have addressed effects of chemicals on the development of mineralized tissues following exposure during these early stages of life. In this experimental study, we analyse...

ba0003pp148 | Cell biology: osteoblasts and bone formation | ECTS2014

Expression of BDNF gene in the femur of aged vs adult rats

Camerino Claudia , Cannone Maria , Heiny Judy , Tricarico Domenico

Brain-derived neurotrophic factor (BDNF) has recently emerged as a factor able to concurrently target age related diseases as neurodegenerative disease, osteoporosis and metabolic syndrome. However the role of BDNF in the frailty syndrome associated with aging has never been investigated. The deletion of central BDNF gene in mice results in increased bone mass and in vitro experiments show that BDNF has a positive effect on bone. BDNF expression is mediated by estroge...

ba0003pp193 | Genetics | ECTS2014

MK-7 enhances expression of genes related to bone, enamel and dentin, and reduces the expression of genes related to apoptosis in developing murine molars

Landin Maria A. , Shabestari Yashar , Sehic Amer , Osmundsen Harald

Introduction: The fat-soluble and vitamin K2 homologe Menaquinone-7 (MK-7) is needed for post-translational modification of proteins essential in blood coagulation, and in metabolic pathways in various tissues like bone. Recent studies found an association between long-term anticoagulant treatment (OAC) and reduced bone quality due to reduction of active osteocalcin. OAC is often linked to an undesired soft-tissue calcification in both children and adults and may lead to incre...

ba0004p101 | (1) | ICCBH2015

X-linked spinal muscular atrophy caused by de novo c.1731C>T substitution in the UBA1 gene

Jedrzejowska Maria , Kostera-Pruszczyk Anna , Jakubowska-Pietkiewicz Elzbieta

Infantile spinal muscular atrophy X-linked 2 (SMAX2) is a rare form of spinal muscular atrophy manifesting in severe hypotonia, areflexia, arthrogryposis, facial weakness and cryptorchidism, as frequently accompanied by bone fractures.We present a boy patient with SMAX2 who presented typical symptoms from birth, as preceded by reduced fetal movements in the second and third trimester of pregnancy. In the first days of life the patient was found to have s...

ba0005p99 | Cancer and bone: basic, translational and clinical | ECTS2016

DNA-methylation status affects prognostic markers of bone metastasis from breast carcinoma

Maroni Paola , Bendinelli Paola , Matteucci Emanuela , Desiderio Maria Alfonsina

Metastasis to bone is the leading cause of death for breast carcinoma, and much focus in the biology and therapy relays on epigenetic alterations. Since DNA-methyltransferase blockade counteracts tumour growth, we utilized 5-aza-2′-deoxycytidine (dAza) to clarify whether molecular events undergoing epigenetic control were critical for bone metastatization. Here, we studied Secreted-Protein Acidic and Rich in Cysteine (SPARC), matricellular glycoprotein associated with bo...

ba0005p293 | Osteoporosis: evaluation and imaging | ECTS2016

DXA in clinical practice: invest in quality to improve accuracy and clinical relevance

Cagnoni Carlo , Gandolfi Stefano , Bibbo Patrizia , Iofrida Mariana , Occhipinti Maria

Introduction: Dual X-ray Absorptiometry (DXA) is currently the best technique available to evaluate bone mass, enabling the diagnosis of osteoporosis, the prediction of fracture risk and monitoring.Clinical good practices consider as preferred measuring sites the lumbar (L1–L4) and proximal femur (neck and total). The vertebral morphometry is a quantitative method for the diagnosis of vertebral fractures based on measuring vertebral heights.<p...

ba0005p356 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

The added value to FRAX of gait speed and tests of postural balance

Lundin Hans , Saaf Maria , Strender Lars-Erik , Salminen Helena

Objectives: Postural balance and gait speed are risk factors for falls and hip fractures independent of bone mineral density (BMD). The standard risk assessment tool, FRAX, does however not include any estimate of fall risk. Identifying high-risk individuals correctly is be of great clinical importance why further improvement of FRAX would be clinically valuable. The primary aim of this study was to see if one-leg standing time, the maximum number of steps on a line or gait sp...

ba0007p96 | (1) | ICCBH2019

Radiofrequency echographic multispectrometry (REMS): a new approach for osteoporosis diagnosis in adolescents

Caffarelli Carla , Pitinca Maria Dea Tomai , Nuti Ranuccio , Gonnelli Stefano

Objective: Dual-energy X-ray absorptiometry (DXA) is the most commonly used method for evaluating bone mineral density (BMD) in children and adolescents. An innovative echographic approach for osteoporosis diagnosis, directly applicable on both femoral neck and lumbar spine, has been recently introduced and clinically validated through single-center and multicenter studies in a adult population. This developed approach has been subsequently defined as Radiofrequency Echographi...

ba0003pp223 | Osteoporosis: evaluation and imaging | ECTS2014

Bone mineral density and bone turnover markers in patients with thyroid cancer and L-T4 suppressive therapy after 25 years of follow-up

de Mingo Dominguez Maria Luisa , Iglesias Sonsoles Guadalix , Alvarez Maria Begona Lopez , Diaz-Guerra Guillermo Martinez , Carranza Federico Hawkins

Background: Patients with differentiated thyroid cancer (DTC) are treated with L-thyroxine (L-T4) in relatively hight doses to suppress endogenous TSH levels. Very long-term effect of thyroid hormones supplementation on bone are controversial.Objetive: To study the possible negative effects on bone mineral density (BMD) and bone markers in DTC patients followed in our center.Methods: A 46 po...